Expandly Blog

EFSA Confirmed Beta-NMN Is Safe. Brands Still Can’t Sell It in the EU Without Approval

EFSA’s May 2026 opinion establishes 300mg/day as safe for adults, but NMN remains a novel food requiring formal EU authorization before it can be included in supplements sold in Europe.

Key Takeaways

►EFSA confirmed beta-NMN safe at 300mg/day for adults in May 2026

►EU Novel Food authorization from European Commission still required

►NMN products cannot legally be sold as EU supplements until authorization is granted

►Monitor the Commission authorization calendar for the final decision date

In May 2026, the European Food Safety Authority issued a positive safety opinion on beta-NMN, confirming it safe for adults at up to 300mg per day. For health and wellness brands tracking NMN's regulatory journey in Europe, this is significant progress. It is not, however, authorization to sell.

300mg per day established as safe for adults by EFSA's May 2026 safety opinion on beta-NMN. Novel Food authorization from the European Commission still required before sale in EU markets.

beta-NMN remains classified as a novel food under EU Regulation 2015/2283. A positive EFSA safety opinion is a required step in the Novel Food authorization process, not the end of it. The European Commission must still grant formal authorization before any brand can include beta-NMN in a supplement product sold within the EU.

For brands currently selling NMN supplements in the US and looking at EU expansion, the timeline now has a clearer shape. The EFSA opinion is on record. The authorization application can proceed. But until the Commission issues its decision, NMN products marketed as supplements cannot legally be sold in EU markets, regardless of the safety data.

The EU Novel Food framework exists specifically to evaluate ingredients that were not in common use in EU food products before May 1997. beta-NMN falls into this category. Brands that have been waiting for the regulatory picture to clear before committing to EU launch will want to monitor the Commission's authorization calendar closely.

For health and wellness brands building an EU expansion plan, understanding which ingredients in your formulations are classified as novel foods -- and where they are in the authorization process -- is foundational compliance work. Expandly's market setup process covers ingredient regulatory status as part of onboarding, so brands know what they can and cannot launch before they commit.

The EFSA opinion is the green light from the science. The market authorization is the green light to sell. They are different steps.

Expandly helps US ecommerce brands expand into Europe — compliance, marketplaces and fulfilment, all handled. We’ve supported 2,000+ brands make the move.

EPR compliance managed from day one — packaging, WEEE, batteries and beyond
Product label review and Responsible Person service for EU and UK market entry

The bigger picture

EU Novel Food Regulation Science Approved. Sale Not Yet.

beta-NMN is one of several high-interest supplement ingredients currently in the EU Novel Food authorization pipeline. Brands building EU product ranges need to map every ingredient in their formulations against the Novel Food catalog before committing to a launch plan. An ingredient that is freely sold in the US may be unauthorized in the EU, either pending a Commission decision or subject to conditions that change the product format entirely. Expandly's compliance onboarding includes an ingredient review as standard, which means a brand knows its full regulatory position before investing in EU-specific inventory, labeling and marketplace setup.

EU Novel Food Regulation 2015/2283 applies to ingredients not in common EU food use before May 1997
EFSA safety opinion is a prerequisite for authorization, not the authorization itself
Products containing unauthorized novel food ingredients cannot legally be placed on EU markets

Global Supplement Demand

43% of global consumers use supplements at least weekly. For US supplement brands looking at EU expansion, that demand base exists across European markets, but the legal pathway to supply it depends on the regulatory status of each ingredient in your formulation.

43%

of global consumers use supplements at least weekly (Euromonitor, February 2025)

EU Supplement Compliance

Directive 2002/46/EC governs food supplement composition and labeling across all 27 EU member states. A Responsible Person designation and product notification are required before any supplement reaches the EU market. Expandly manages both as part of your market setup.

EU member states governed by Directive 2002/46/EC on food supplements

Compliant Before It Ships

EU product compliance is a prerequisite for selling, not something to address after launch. Expandly audits products against applicable directives before anything reaches a marketplace or leaves a warehouse.

2,000+

brands expanded with Expandly

If this sounds like your world,
let's talk.

Expandly helps US ecommerce brands expand into Europe — compliance, marketplaces and fulfilment, all handled.

Global Expansion Pathway™

Where to Expand

Expandly Blog

EFSA Confirmed Beta-NMN Is Safe. Brands Still Can’t Sell It in the EU Without Approval

In This Article

Key Takeaways

The bigger picture

EU Novel Food Regulation Science Approved. Sale Not Yet.

If this sounds like your world, let's talk.

Self-Serve

Guided

VIP

If this sounds like your world,
let's talk.